Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University / Abhinav Dey, PhD |
Young Investigator Grants |
2015 |
Georgia |
The Effect of Locus of Care Upon Adolescent and Young Adults Cancer Outcomes: An IMPACT Cohort Study |
Hospital for Sick Children / Sumit Gupta, MD, PhD |
Young Investigator Grants |
2015 |
Ontario |
Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia |
University of California San Francisco / Elliot Stieglitz, MD |
Young Investigator Grants |
2015 |
California |
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children's Hospital of Philadelphia / Robyn Sussman, PhD |
Young Investigator Grants |
2015 |
Pennsylvania |
The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis |
Dana-Farber Cancer Institute / Ting Tao, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Novel Nanoscale Phosphoproteomic Discovery of Therapeutic Targets in AML Stem Cells |
Dana-Farber Cancer Institute / Leo Wang, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Functional Dissection of Oncogenic Enhancers in T-ALL |
Columbia University / Daniel Herranz, PhD |
Young Investigator Grants |
2015 |
New York |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |